Hip-resection arthroplasty: A valuable treatment for complex hip prosthetic joint infection? - 16/04/25

Doi : 10.1016/j.otsr.2025.104243

Lou Macaux ^a,^b, Benjamin Levavasseur ^a, Younes Kerroumi ^a, Thomas Aubert ^a,^c, Maiwenn Prunel ^a, Beate Heym ^a,^b, Simon Marmor ^a,^c, Valérie Zeller ^a,⁎
^a Centre de Référence des Infections Ostéo-Articulaires Complexes, Groupe Hospitalier Diaconesses Croix Saint-Simon, 125 rue d’Avron, 75020 Paris, France
^b Laboratoire des Centres de Santé et Hôpitaux Île-de-France, Groupe Hospitalier Diaconesses Croix Saint-Simon, 125 rue d’Avron, 75020 Paris, France
^c Service de Chirurgie Osseuse et Traumatologique, Groupe Hospitalier Diaconesses Croix Saint-Simon, 125 rue d’Avron, 75020 Paris, France

^⁎Corresponding author.

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Wednesday 16 April 2025
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Introduction

Management of recurrent hip prosthetic joint infection (PJI) is challenging. Hip-resection arthroplasty is a last-choice rescue strategy for complex PJI. The main objective was to assess prospectively the mid-term infectious and functional PJI outcomes of patients managed with hip-resection arthroplasty.

Hypothesis

In complex multi-operated PJI, hip-resection arthroplasty may cure the infection without any major impact on hip function, which is often already very limited.

Material and methods

This prospective cohort study conducted in a French Referral Center for bone-and-joint infections included all hip PJIs treated with hip-resection arthroplasty from 2004 to 2019. Patients were followed for at least 2 years, with recording of the following events: reinfection, including relapse or new infection, and PJI-related death. Hip functional status was assessed with the modified Merle d’Aubigné-Postel (mMAP) score. The primary outcome was 2-year event-free survival (EFS). The secondary outcomes were the 4- and 6-year EFS rates and hip functional status at 2 years.

Results

We included 30 patients: median age, 65 years; 39% women. Median [IQR] PJI duration was 15 [4–39] months and patients underwent a median of 5 surgical procedures before resection arthroplasty. The 2-year reinfection free-survival was 89.2% (95% CI: 70.2–96.4). After a median follow-up of 70 [32–103] months, we observed: 1 relapse, 4 new infections, 7 revisions for mechanical reasons and 1 PJI-related death. Median mMAP score 2 years postsurgery was 12, versus 7 before; pain reduction was the main benefit of resection arthroplasty.

Discussion

Hip-resection arthroplasty achieves sepsis and pain control, and can be a valuable last-line rescue strategy for patients with complex or recurrent hip PJIs.